Literature DB >> 1868037

Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma.

U S Bergerheim1, K Kunimi, V P Collins, P Ekman.   

Abstract

In an allelotyping study prostatic carcinoma, we found the highest frequency of allelic deletions on chromosomes 8, 10, 16, and 18. In all cases with allelic deletions, at least one of the chromosomes 8, 10, and 16 were involved. A detailed deletion mapping of these chromosomes in 18 cases was carried out with probes that detect restriction fragment length polymorphisms (RFLP) on chromosomes 8 (6 probes), 10 (11 probes), and 16 (9 probes). The highest frequency of allelic deletions were found on 8p (65%), where the minimally deleted region was between the PLAT locus and pter. The long arm of chromosome 16 had allelic deletions in 56% of informative cases, with three different break points, the most distal being located between D16S4 and D16S7. Chromosome 10 exhibited a complex deletion pattern with terminal deletions of the p or the q arm (2 cases each), a deletion pattern that could be interpreted as nonreciprocal translocations of the q arm (2 cases), or allelic losses on all informative loci, suggesting monosomy (2 cases). Our data suggest that tumor suppressor genes involved in the oncogenesis of prostatic carcinoma may be localized between 8 pter and the PLAT locus and that additional/alternative tumor suppressor genes may be localized on chromosome 10 and on the long arm of chromosome 16 distal to the D16S4 locus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1868037     DOI: 10.1002/gcc.2870030308

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  50 in total

Review 1.  Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents.

Authors:  R Montironi; R Mazzucchelli; J R Marshall; P H Bartels
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

2.  A genome screen of multiplex sibships with prostate cancer.

Authors:  B K Suarez; J Lin; J K Burmester; K W Broman; J L Weber; T K Banerjee; K A Goddard; J S Witte; R C Elston; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

3.  Cadherins, steroids and cancer.

Authors:  O W Blaschuk; S B Munro; R Farookhi
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

4.  Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1.

Authors:  Chun-Xiao Yu; Tong Jin; Wei-Wen Chen; Peng-Ju Zhang; Wen-Wen Liu; Heng-Yun Guan; Ju Zhang; Qing-Wei Liu; An-Li Jiang
Journal:  Mol Biol Rep       Date:  2009-03-05       Impact factor: 2.316

5.  DNA polymerase β promoter mutations and transcriptional activity in esophageal squamous cell carcinoma.

Authors:  Min Li; Wenqiao Zang; Yuanyuan Wang; Yuebai Li; Yunyun Ma; Na Wang; Yue Tang; Lulu Liu; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2013-06-08

6.  Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

Authors:  S F Huang; S Xiao; A A Renshaw; K R Loughlin; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 7.  Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.

Authors:  J T Isaacs
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

8.  Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.

Authors:  T Ueda; T Ichikawa; J Tamaru; A Mikata; K Akakura; S Akimoto; T Imai; O Yoshie; T Shiraishi; R Yatani; H Ito; J Shimazaki
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

9.  Deletion mapping of chromosome 8p in colorectal carcinoma and dysplasia arising in ulcerative colitis, prostatic carcinoma, and malignant fibrous histiocytomas.

Authors:  M Chang; K Tsuchiya; R H Batchelor; P S Rabinovitch; B G Kulander; R C Haggitt; G C Burmer
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

10.  NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.

Authors:  Xiang Li; Bin Guan; Sam Maghami; Charles J Bieberich
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.